iCAD features AI software for breast imaging at RSNA

Computer-aided detection (CAD) software developer iCAD is showcasing its Breast...Read more on AuntMinnie.comRelated Reading: iCAD features Xoft Axxent upgrades at ASTRO 2019 iCAD partners with Swedish team on AI for breast cancer iCAD to highlight AI for tomosynthesis at ECR iCAD gets FDA nod for ProFound AI software for DBT iCAD touts clinical results with Xoft Axxent brachytherapy
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Intraoperative radiation therapy is an emerging option for adjuvant therapy for early stage breast cancer, although it is not currently considered standard of care in the United States. We applied time-driven activity-based costing to compare two alternative methods of breast intraoperative radiation therapy, including treatment similar to the techniques employed in the TARGIT-A clinical trial and a novel version with CT-guidance and high-dose-rate (HRD) brachytherapy.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
Abstract Brachytherapy is an invasive therapy with placement of radiation source into or near the tumor. The difference between planning target volume and clinical target volume is minimal, and the dose out of the tumor reduces rapidly due to the inverse-square law. High-dose-rate brachytherapy enables three-dimensional image guidance, and currently, tumor dose as well as doses of the surrounding normal structures can be evaluated accurately. High-dose-rate brachytherapy is the utmost precision radiation therapy even surpassing carbon ion therapy. Biological disadvantages of high-dose rate have been overcome by th...
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Tags: Jpn J Clin Oncol Source Type: research
Publication date: Available online 5 December 2019Source: The LancetAuthor(s): Frank A Vicini, Reena S Cecchini, Julia R White, Douglas W Arthur, Thomas B Julian, Rachel A Rabinovitch, Robert R Kuske, Patricia A Ganz, David S Parda, Michael F Scheier, Kathryn A Winter, Soonmyung Paik, Henry M Kuerer, Laura A Vallow, Lori J Pierce, Eleftherios P Mamounas, Beryl McCormick, Joseph P Costantino, Harry D Bear, Isabelle GermainSummaryBackgroundWhole-breast irradiation after breast-conserving surgery for patients with early-stage breast cancer decreases ipsilateral breast-tumour recurrence (IBTR), yielding comparable results to m...
Source: The Lancet - Category: General Medicine Source Type: research
We report the first results of IORT with this system in Bulgaria.
Source: Physica Medica: European Journal of Medical Physics - Category: General Medicine Authors: Source Type: research
To dosimetrically compare interstitial brachytherapy (MIBT) vs. EBRT (3DCRT and high-energy electron beams) for deep-seated tumor bed boosts (depth ≥4 cm) in early-stage breast cancer.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation w...
Source: Cancer Radiotherapie - Category: Cancer & Oncology Authors: Tags: Cancer Radiother Source Type: research
Conclusions: This study is the first stage of the dosimetric evaluation of a new method. The analysis allows treating complex localizations of the breast cancer, for example, in a close position to the skin or ribs. In order to minimize the toxic effects, it is necessary to consider patient selection, catheter administration, and dose optimization. PMID: 31523236 [PubMed]
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Computer-aided detection (CAD) software developer iCAD is showcasing the latest...Read more on AuntMinnie.comRelated Reading: iCAD partners with Swedish team on AI for breast cancer iCAD to highlight AI for tomosynthesis at ECR iCAD touts clinical results with Xoft Axxent brachytherapy iCAD highlights study results of DBT software FDA OKs iCAD's breast density AI software
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
A common treatment option for breast cancer patients is accelerated partial breast irradiation (APBI) often applied in form of high dose-rate (HDR) multi-catheter interstitial brachytherapy (iBT). The therapy outcome proved to be comparable to other treatment options, such as whole breast irradiation or a percutaneous APBI treatment, with regards to local recurrence rate, disease free survival, overall survival, quality of life, late side effects, toxicity and cosmetic outcome [1 –8]. APBI using multi-catheter iBT is defined as irradiation to a predefined clinical target volume encompassing the tumor bed and a surgic...
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: Original Article Source Type: research
CONCLUSIONS: Overall cosmetic outcomes as well as individual subdomains are significantly better with APBI as compared to WBRT by all methods of assessment of cosmesis when matched for various factors. PMID: 31512161 [PubMed - as supplied by publisher]
Source: Breast Cancer - Category: Cancer & Oncology Authors: Tags: Breast Cancer Source Type: research
More News: Brachytherapy | Breast Cancer | Cancer | Cancer & Oncology | Computers | Radiology | Sweden Health